Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture
Vertebral augmentation procedures are widely used to treat osteoporotic vertebral compression fractures (VCFs). We report our initial experience with radiofrequency-targeted vertebral augmentation (RF-TVA) in 20 patients aged 50 to 90 years with single-level, symptomatic osteoporotic VCF between T10...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.1155/2013/791397 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560740398006272 |
|---|---|
| author | Franklin G. Moser Marcel M. Maya Laura Blaszkiewicz Andrea Scicli Larry E. Miller Jon E. Block |
| author_facet | Franklin G. Moser Marcel M. Maya Laura Blaszkiewicz Andrea Scicli Larry E. Miller Jon E. Block |
| author_sort | Franklin G. Moser |
| collection | DOAJ |
| description | Vertebral augmentation procedures are widely used to treat osteoporotic vertebral compression fractures (VCFs). We report our initial experience with radiofrequency-targeted vertebral augmentation (RF-TVA) in 20 patients aged 50 to 90 years with single-level, symptomatic osteoporotic VCF between T10 and L5, back pain severity > 4 on a 0 to 10 scale, Oswestry Disability Index ≥ 21%, 20% to 90% vertebral height loss compared to adjacent vertebral body, and fracture age < 6 months. After treatment, patients were followed through hospital discharge and returned for visits after 1 week, 1 month, and 3 months. Back pain severity improved 66% (P<0.001), from 7.9 (95% CI: 7.1 to 8.6) at pretreatment to 2.7 (95% CI: 1.5 to 4.0) at 3 months. Back function improved 46% (P<0.001), from 74 (95% CI: 69% to 79%) at pretreatment to 40 (95% CI: 33% to 47%) at 3 months. The percentage of patients regularly consuming pain medication was 70% at pretreatment and only 21% at 3 months. No adverse events related to the device or procedure were reported. RF-TVA reduces back pain severity, improves back function, and reduces pain medication requirements with no observed complications in patients with osteoporotic VCF. |
| format | Article |
| id | doaj-art-76f0ae2489d4452db6e6a0dc89ae2150 |
| institution | Kabale University |
| issn | 2090-8059 2042-0064 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Osteoporosis |
| spelling | doaj-art-76f0ae2489d4452db6e6a0dc89ae21502025-02-03T01:26:47ZengWileyJournal of Osteoporosis2090-80592042-00642013-01-01201310.1155/2013/791397791397Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression FractureFranklin G. Moser0Marcel M. Maya1Laura Blaszkiewicz2Andrea Scicli3Larry E. Miller4Jon E. Block5Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USACedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USACedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USADFINE, Inc., 3047 Orchard Parkway, San Jose, CA 95134, USAMiller Scientific Consulting, Inc., 26 Portobello Road, Arden, NC 28704, USAThe Jon Block Group, 2210 Jackson Street, Suite 401, San Francisco, CA 94115, USAVertebral augmentation procedures are widely used to treat osteoporotic vertebral compression fractures (VCFs). We report our initial experience with radiofrequency-targeted vertebral augmentation (RF-TVA) in 20 patients aged 50 to 90 years with single-level, symptomatic osteoporotic VCF between T10 and L5, back pain severity > 4 on a 0 to 10 scale, Oswestry Disability Index ≥ 21%, 20% to 90% vertebral height loss compared to adjacent vertebral body, and fracture age < 6 months. After treatment, patients were followed through hospital discharge and returned for visits after 1 week, 1 month, and 3 months. Back pain severity improved 66% (P<0.001), from 7.9 (95% CI: 7.1 to 8.6) at pretreatment to 2.7 (95% CI: 1.5 to 4.0) at 3 months. Back function improved 46% (P<0.001), from 74 (95% CI: 69% to 79%) at pretreatment to 40 (95% CI: 33% to 47%) at 3 months. The percentage of patients regularly consuming pain medication was 70% at pretreatment and only 21% at 3 months. No adverse events related to the device or procedure were reported. RF-TVA reduces back pain severity, improves back function, and reduces pain medication requirements with no observed complications in patients with osteoporotic VCF.http://dx.doi.org/10.1155/2013/791397 |
| spellingShingle | Franklin G. Moser Marcel M. Maya Laura Blaszkiewicz Andrea Scicli Larry E. Miller Jon E. Block Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture Journal of Osteoporosis |
| title | Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture |
| title_full | Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture |
| title_fullStr | Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture |
| title_full_unstemmed | Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture |
| title_short | Prospective Single-Site Experience with Radiofrequency-Targeted Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture |
| title_sort | prospective single site experience with radiofrequency targeted vertebral augmentation for osteoporotic vertebral compression fracture |
| url | http://dx.doi.org/10.1155/2013/791397 |
| work_keys_str_mv | AT franklingmoser prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture AT marcelmmaya prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture AT laurablaszkiewicz prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture AT andreascicli prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture AT larryemiller prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture AT joneblock prospectivesinglesiteexperiencewithradiofrequencytargetedvertebralaugmentationforosteoporoticvertebralcompressionfracture |